Wed.Jul 17, 2024

article thumbnail

Rite Aid Addresses Cyberattack: 2.2 Million Customers’ Data Breached

Drug Topics

The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.

209
209
article thumbnail

Vaccination slashes risk of long Covid, says large study tracing cases through Delta and Omicron variants

STAT

Vaccination lowers the chance of developing long Covid, according to a large new study that also found that the risk of serious complications has diminished but not disappeared as new coronavirus variants emerged. The study, published Wednesday in the New England Journal of Medicine , compared the health records of more than 440,000 Veterans Affairs patients who were infected with Covid-19 with records of more than 4 million uninfected people.

Vaccines 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pembrolizumab and Radiotherapy Treatment Demonstrates Efficacy in Patients With Relapsed, Refractory Multiple Myeloma

Pharmacy Times

Radiotherapy may have applications beyond symptomatic relief when used in combination with immunotherapy.

132
132
article thumbnail

As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will move on without them

STAT

Around the world, patients suddenly can’t find enough of the insulins made by companies they have long relied on to do so. In the U.S., Novo Nordisk’s recent decision to discontinue a product has left patients with fewer options. At the same time, patients are encountering shortages of other products from Novo and Eli Lilly. For months, pharmacies have been running out of vials of certain insulins that patients use to fill the pumps they wear on their body.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Better Prevention Strategies Rely on the Monitoring of Outpatient Adverse Drug Events

Pharmacy Times

Currently, limited data show the effect of adverse drug events in the outpatient setting.

132
132
article thumbnail

Bone marrow donors needn’t be perfect match, study says, paving way for more equitable access

STAT

As a hematologist-oncologist in Miami, Mikkael Sekeres always hopes his patients will find a perfect match for the bone marrow transplant they need to save their lives — but he doesn’t expect it. Most of his patients are Latino or African American, and rates of perfect matches are much lower for racial or ethnic minorities. That gloomy picture could soon change.

141
141

More Trending

article thumbnail

STAT+: Gilead’s chief medical officer to leave as R&D efforts stall

STAT

Gilead Sciences’ chief medical officer will leave the company early next year as the drugmaker struggles to find new areas of growth beyond its core portfolio of HIV medicines. Merdad Parsey, who joined Gilead in 2019, will stay in his post until the first quarter of next year as the company looks for a successor, Gilead said in a press release Wednesday.

136
136
article thumbnail

Healthcare costs set to rise by as much as 8% in 2025: PwC

Fierce Healthcare

Healthcare costs are set to rise between 7% and 8% in 2025, according to a new report from PwC. | Healthcare costs are set to rise between 7% and 8% in 2025, according to a new report from PwC.

131
131
article thumbnail

STAT+: A second Roche obesity drug shows promise in early studies

STAT

LONDON — Roche on Wednesday reported positive early data from another of the obesity drug candidates that it picked up through an acquisition late last year, bolstering the case it could become a player in the competitive weight-loss medicine field.   The company said its once-daily pill, called CT-996, led to a placebo-adjusted average weight loss of 6.1% after four weeks in patients with obesity who did not have diabetes.

136
136
article thumbnail

AI-generated messages to patients on par with clinicians, and can even be more empathetic, study finds

Fierce Healthcare

Electronic health record messages to patients drafted by generative AI were of similar quality and accuracy to those written by healthcare professionals, according to a newly published study conduc | A blind analysis of hundreds of EHR message drafts found similar quality and usability. Generative AI's contributions were more empathetic, but also tended to be longer and more linguistically complex.

131
131
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Elevance tumbles as health insurer warns Medicaid members are using more care

STAT

Wall Street’s reaction was swift Wednesday after Elevance Health said that the amount of care its Medicaid members are getting is outpacing what states are paying the insurer to treat those members. Elevance’s stock tumbled almost 6% even though the company reported earnings that beat Wall Street’s estimates, and a slightly higher operating gain in the second quarter of 2024 compared with the prior-year period.

Insurance 136
article thumbnail

Northwell Health teams up with Instacart to scale food-as-health programs

Fierce Healthcare

Grocery delivery company Instacart continues to expand its reach in healthcare and has notched a major health system partnership. | The first program to launch integrates Instacart Health tools into Northwell’s Center for Maternal Health Maternal Outcomes and Morbidity Collaborative (MOMS) so that moms-to-be who are food insecure have improved access to fresh and nutritious food.

128
128
article thumbnail

Opinion: Listen: Empathy should be the first response to people with vaccine injury, fears

STAT

For scientists and medical professionals well versed in the safety and effectiveness of vaccines, it is often too easy to write off the concerns of people who fear them, or feel they have been injured by them. But vaccine expert Kizzmekia S. Corbett-Helaire argues that professionals should be more empathetic when it comes to listening to these concerns, and that understanding them may help developers make better vaccines.

Vaccines 131
article thumbnail

Bayer’s Nubeqa, en route to blockbusterland, clinches 2nd win in prostate cancer subtype

Fierce Pharma

Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer (mHSPC). | Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer.

126
126
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: Data privacy startup raises $30 million, to ease health care providers’ regulatory burden

STAT

Federal guidance restricting hospital websites’ use of third-party trackers along with the proliferation of direct-to-consumer health services is spawning a new crop of health tech startups promising to help beleaguered providers stay on the right side of the law. Among them is San Francisco startup Freshpaint, which on Wednesday announced a $30 million Series B round to sell its privacy platform to providers, pharmacies, insurers.

Insurance 131
article thumbnail

Severe Pemphigus Vulgaris Successfully Treated With Intravenous Immunoglobulin

Pharmacy Times

A patient with severe and recurrent pemphigus vulgaris achieved lasting remission with a novel intravenous immunoglobulin preparation that had the added benefit of reducing treatment-related side effects.

123
123
article thumbnail

STAT+: Why clinical trials for digital therapeutics are getting more rigorous

STAT

Faced with widespread skepticism about the value of digital therapies, Swing Therapeutics in early 2022 set out to make the strongest case possible for its app-based treatment for fibromyalgia. In a year-long pivotal trial for Swing’s treatment, called Stanza, participants were told they were receiving one of two potentially effective treatments for fibromyalgia.

FDA 130
article thumbnail

Optimizing the Upcoming Influenza Season

Pharmacy Times

Many ways exist to best serve communities and the bottom line beyond vaccine ordering and increased staffing.

Vaccines 122
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: With resignations of top leaders, Cassava Sciences exposes a dark, ugly corner of the Alzheimer’s disease world

STAT

Cassava Sciences is imploding — and as it crumbles, a dark, ugly corner of the Alzheimer’s disease world is being exposed and will hopefully get cleaned up. Remi Barbier, Cassava’s longtime CEO, has resigned and is also leaving the board, the company announced Wednesday. Lindsay Burns, Cassava’s senior vice president of neuroscience, is gone, too.

129
129
article thumbnail

Sanofi to more than double its workforce at Hyderabad site with $437M expansion: reports

Fierce Pharma

Sanofi is looking to bulk up its workforce at its global capacity center in Hyderabad, India, with a multi-year investment totaling 400 million euros ($437 million), according to reports. | The drugmaker plans to grow it its workforce at the site to 2,600, making it the largest of Sanofi's four global capacity centers, according to reports.

119
119
article thumbnail

STAT+: A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down

STAT

A clutch of headlines last week suggested the U.S. Senate had achieved a breakthrough in the battle to prevent pharmaceutical companies from abusing the patent system, an issue that has been blamed for boosting prescription drug costs for Americans. But while the Senate bill  clearly represents a step forward, the impact will not be nearly as great as originally intended by lawmakers due to industry lobbying.

article thumbnail

Elevance Health beats the Street in Q2 as it posts $2.3B in profit

Fierce Healthcare

Elevance Health beat the Street on both profit and revenue in the second quarter, according to its earnings report released on Wednesday.

115
115
article thumbnail

J&J keeps growth projections afloat as it braces for IRA price negotiation impact

Fierce Pharma

As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations. | As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations.

114
114
article thumbnail

Children with T1D at Increased Risk of Psychiatric Disorders Later in Life

Drug Topics

Patients with childhood type 1 diabetes were more likely to develop substance use disorders, mood disorders, anxiety disorders, and behavioral syndromes.

112
112
article thumbnail

New Data Suggest Vaccination Reduces Risk of Developing Long Covid

Pharmacy Times

Investigators found that the risk of long COVID decreased over the course of the pandemic.

Vaccines 111
article thumbnail

Roche reveals first data with Carmot-sourced oral GLP-1 drug

pharmaphorum

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.

111
111
article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

The FDA Law Blog

By Sarah Wicks & James E. Valentine & Frank J. Sasinowski — On July 17, 2024, FDA announced the establishment of a Rare Disease Innovation Hub (the “Hub”) to enhance and improve outcomes for patients with rare diseases and conditions by focusing on rare disease drug and biological product development across the Agency’s Center for Drug Evaluation and Research (“CDER”) and Center for Biologics Evaluation and Research (“CBER”).

FDA 105
article thumbnail

12 Questions with Dr James Burt

pharmaphorum

Get insights into Dr James Burt's leadership as CEO of Pharmanovia through a 12-question interview that covers his background, achievements, and vision for the company.

111
111
article thumbnail

Allergy Medications As Deprescribing Targets

Med Ed 101

Allergic rhinitis is a very common condition. I’ve encountered numerous patients throughout my career who take more than one medication to help keep their symptoms at bay. When reviewing polypharmacy cases, I do consider allergy medications as deprescribing targets because oftentimes allergy medications are added and the original success of the first agent is not […] The post Allergy Medications As Deprescribing Targets appeared first on Med Ed 101.

105
105
article thumbnail

Drug development and compliance: 4 Ways AI is impacting pharma

pharmaphorum

Discover how artificial intelligence is revolutionising drug development and compliance in the pharmaceutical industry with these four impactful ways.

109
109
article thumbnail

STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

103
103
article thumbnail

Huma raises $80m, launches 'Shopify for digital health'

pharmaphorum

Huma raised $80m to support a cloud platform that can be used by digital health developers to create disease management tools

105
105
article thumbnail

PQA Pilots of Pharmacy Measure Concepts Demonstrate Positive Pharmacy Impact on Blood Pressure and Diabetes Clinical Endpoints

Drug Topics

Opportunities, Challenges Persist Related to Pharmacy Data Capture and Exchange

98